Showing results (11-20 of 98) with videos related to
Sort By:
Pageof 10
Lung Cancer (Amsterdam, Netherlands)|October 11, 2007
Survival improvement in thoracic cancer: progress from the last decade and beyondChristian Manegold, Nicholas ThatcherSeminars in Oncology|February 1, 2017
Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: An international updateMark G Kris, Christian ManegoldLung Cancer (Amsterdam, Netherlands)|July 18, 2003
Advanced NSCLC: new cytostatic agentsParis A Kosmidis, Christian ManegoldTranslational Lung Cancer Research|March 26, 2015
Targeting angiogenesis in lung cancer - Pitfalls in drug developmentWolfgang Hilbe, Christian Manegold, Andreas PircherTranslational Lung Cancer Research|March 26, 2015
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer?Lothar R Pilz, Christian Manegold, Gerald Schmid-BindertExpert Review of Anticancer Therapy|September 19, 2009
Pemetrexed for the treatment of non-small-cell lung cancerChristian Manegold, Gerald Schmid-Bindert, Lothar R PilzJournal of Andrology|May 11, 2002
Effect of carboplatin on the functional integrity of the human sperm membrane in vitroWerner J Reiter, Sandra Tomek, Christoph C Zielinski, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosisErika Buchholz, Christian Manegold, Lothar Pilz, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 2, 2011
Bevacizumab-induced hypertension: pathogenesis and managementKostas N Syrigos, Eleni Karapanagiotou, Paraskevi Boura, et al.Clinical Lung Cancer|June 10, 2005
A pilot trial of gefitinib in combination with docetaxel in patients with locally advanced or metastatic non-small-cell lung cancerChristian Manegold, Ulrich Gatzemeier, Erika Buchholz, et al.Pageof 10